Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 131 (ZNF131) is a member of the BTB (POZ) and zinc finger domain-containing transcription factors, functioning primarily as a transcriptional regulator. It enables sequence-specific DNA binding and acts as a transcription repressor, particularly by inhibiting estrogen receptor alpha (ERα) signaling through direct interaction and suppression of its homo-dimerization. ZNF131 is involved in the negative regulation of gene expression mediated by RNA polymerase II, regulation of cytokine production, and immune system processes. It is expressed in the nucleoplasm and intermediate filament cytoskeleton. ZNF131 plays developmental roles, especially in the central nervous system, and has been implicated in oncogenic processes, such as promoting cell proliferation in gastric and liver cancers. SUMOylation of ZNF131 enhances its transcriptional repressor activity and its ability to inhibit estrogen receptor signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 131 (ZNF131).